2023-08-012024-05-15https://scholars.lib.ntu.edu.tw/handle/123456789/664605Combining a Novel Affibody-Conjugated Prodrug System with Radiotherapy to Enhance Antitumor Effects ― Targeting Her2-Positive Tumors